President: Drug Discovery & Development | Drug Target Strategy | Ip Conception | Medicinal Chemistry
CurrentRecent consultation has included:• Steering committee member for an international start-up. Advise in strategic direction, drug target selection and delivery as well as generation of intellectual property.• Conducted due diligence for a company assessing potential collaboration/acquisition of assets for therapeutic targets that include CNS, IBD/UC and fibrosis.• Consulted for a pharma/start-up collaboration assessing anti-cancer molecules for expansion to a novel therapeutic target.• Expert witness for Gilead in a patent infringement case related to Biktarvy®HIV treatment. Case settled favorably.Core competencies:• Drug discovery & development• Medicinal Chemistry• Target and lead identification/optimization• Oral, topical and device drug delivery• Prodrugs and conjugates• Small molecule agonists/antagonists• Research strategy and direction• Conception of intellectual property• Expert witness